Professional Summary

Professional Overview

Paul Giese is an experienced financial professional and the Founder of OptimalData Consulting, where he provides strategic advisory services to clients in the life sciences and technology industries. With a strong background in accounting, financial analysis, and business operations, he leverages his expertise to help organizations optimize their data-driven decision-making and achieve sustainable growth.

Experience Summary

Current Role

As the Founder of OptimalData Consulting, Paul is responsible for guiding clients through complex financial and operational challenges, implementing tailored solutions, and driving long-term organizational success. He works closely with executive teams to analyze data, identify opportunities for improvement, and develop strategic roadmaps that align with their business objectives.

Career Progression

Prior to founding OptimalData Consulting, Paul held several senior-level accounting and financial roles, including positions at Danforth Advisors, Surface Oncology Inc., Claritas Genomics, and Infraredx, Inc. Throughout his career, he has consistently demonstrated a keen ability to optimize financial processes, improve reporting accuracy, and enhance the overall financial health of the organizations he has served.

Academic Background

Paul holds a Bachelor of Science degree in Accounting from the University of Texas at Austin, where he graduated cum laude. He is a Certified Public Accountant (CPA) and maintains a strong commitment to ongoing professional development, staying abreast of industry trends and best practices.

Areas of Expertise

• Financial reporting and analysis

• Accounting and audit processes

• Data-driven decision-making

• Business operations optimization

• Strategic planning and implementation

• Leadership and team management

Professional Impact

During his tenure at Surface Oncology Inc., Paul played a pivotal role in streamlining the company's accounting systems, improving financial reporting accuracy, and enhancing the overall financial controls. This contributed to the organization's successful Series B financing round, which raised $108 million to support its clinical development initiatives.

Conclusion

With his deep understanding of the financial and operational challenges faced by life sciences and technology companies, Paul Giese is a trusted advisor who helps clients navigate complex business environments and achieve sustainable growth. His proven track record of success, coupled with his dedication to delivering exceptional results, positions him as a valuable asset to the organizations he serves.